Zimmer Biomet Holdings (ZBH) Liabilities from Discontinued Operations (2021)
Zimmer Biomet Holdings' quarterly Liabilities from Discontinued Operations came in at 61300000.0 in Q4 2021.
Zimmer Biomet Holdings has reported Liabilities from Discontinued Operations for 1 years, with the latest figure at 61300000.0 in Q4 2021.
- For the quarter ending Q4 2021, Liabilities from Discontinued Operations changed N/A year-over-year to 61300000.0; the trailing twelve-month figure through Dec 2021 stood at 61300000.0 (changed N/A YoY), and the FY2021 full-year result was 61300000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q4 2021 stood at 61300000.0.
- The five-year high for Liabilities from Discontinued Operations was 61300000.0 in Q4 2021, with the low at 61300000.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 61.30 Mn |
| Dec 31, 2021 | 61.30 Mn |